Diagnostic Process for Seronegative Spondyloarthropathies
The diagnosis of seronegative spondyloarthropathies requires a combination of clinical assessment, laboratory testing, and appropriate imaging studies, with MRI being the most sensitive tool for early detection of inflammatory changes before radiographic damage occurs. 1
Clinical Evaluation
Key Clinical Features to Identify
- Inflammatory back pain (onset before age 45, duration >3 months)
- Morning stiffness lasting >30 minutes
- Pain that improves with exercise but not rest
- Nocturnal awakening due to pain (especially in second half of night)
- Alternating buttock pain 1, 2
- Peripheral manifestations:
- Extra-articular manifestations:
- Psoriatic plaques or nail changes
- Eye inflammation (uveitis)
- Inflammatory bowel disease symptoms 3
Laboratory Testing
- HLA-B27 testing (positive in many but not all cases)
- Important: A negative HLA-B27 test does not rule out seronegative spondyloarthropathies 2
- C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR)
- May be elevated but can be normal in up to 50% of cases 2
- Rheumatoid factor (RF) - negative by definition
- Anti-citrullinated protein antibodies (ACPA) - negative
Imaging Studies
Step 1: Radiography
- First-line imaging for suspected sacroiliitis 1
- Evaluate sacroiliac joints for:
- Erosions
- Joint space narrowing or widening
- Sclerosis
- Ankylosis 1
- For peripheral symptoms, obtain radiographs of hands and feet 2
Step 2: MRI (if radiographs are negative or equivocal)
- Most sensitive for early inflammatory changes before radiographic damage 1
- Protocol should include:
- T1-weighted sequences
- Fat-suppressed fluid-sensitive sequences (T2-weighted fat-suppressed or STIR)
- Optional: Gadolinium contrast-enhanced T1-weighted fat-saturated sequences 1
- Key findings:
- Bone marrow edema
- Synovitis
- Enthesitis
- Erosions 1
Step 3: Additional Imaging (if needed)
- CT scan: Better for detecting subtle erosions and structural changes when MRI cannot be performed 1
- Ultrasound: Useful for peripheral joints to detect:
- Synovial hypertrophy
- Hyperemia on color Doppler
- Erosions 1
Classification Criteria
CASPAR Criteria for Psoriatic Arthritis
- Established inflammatory arthritis with ≥3 points from:
- Current psoriasis (2 points), history of psoriasis (1 point), or family history (1 point)
- Nail dystrophy (1 point)
- Negative rheumatoid factor (1 point)
- Current or history of dactylitis (1 point)
- Radiographic evidence of juxta-articular new bone formation (1 point) 1
ASAS Classification for Axial Spondyloarthritis
- Back pain ≥3 months, age of onset <45 years, plus either:
- Sacroiliitis on imaging plus ≥1 SpA feature, OR
- HLA-B27 positive plus ≥2 SpA features 1
Differential Diagnosis
- Rheumatoid arthritis (distinguished by symmetric polyarthritis, rheumatoid nodules, high RF titers) 1
- Osteoarthritis (distinguished by mechanical rather than inflammatory pattern) 1
- Mechanical back pain (lacks inflammatory features, morning stiffness) 1
- Diffuse idiopathic skeletal hyperostosis (DISH)
- Spinal fractures (consider in case of sudden change in symptoms) 1
Common Pitfalls to Avoid
Overlooking seronegative spondyloarthropathy due to negative HLA-B27 - The diagnosis should be based on clinical features and imaging, not solely on HLA-B27 status 2
Relying only on radiographs - Radiographic changes often lag behind clinical symptoms by 7+ years; MRI is essential for early diagnosis 1
Missing peripheral manifestations - Enthesitis and peripheral arthritis may be the predominant features in some patients 2
Failing to consider subtypes - Seronegative spondyloarthropathies include ankylosing spondylitis, psoriatic arthritis, reactive arthritis, enteropathic arthritis, and undifferentiated spondyloarthropathy 4
Overlooking extra-articular manifestations - Particularly uveitis, which requires immediate ophthalmology referral 2
By following this structured diagnostic approach and avoiding common pitfalls, clinicians can effectively diagnose seronegative spondyloarthropathies and initiate appropriate treatment to prevent disease progression and improve patient outcomes.